
<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
      
        <link rel="canonical" href="http://spbm.ohio.gainwelltechnologies.com/UPDL%20and%20Supporting%20Documents/ePA%20Question%20Sets/analgesic_opioids/">
      
      
        <link rel="prev" href="../analgesic_NSAID/">
      
      
        <link rel="next" href="../blood_oral_anticoagulants/">
      
      
      <link rel="icon" href="../../../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.6.1, mkdocs-material-9.5.36">
    
    
      
        <title>Analgesic Agents - Opioids - Ohio SPBM Demo</title>
      
    
    
      <link rel="stylesheet" href="../../../assets/stylesheets/main.06209087.min.css">
      
        
        <link rel="stylesheet" href="../../../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
      
    
    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
    <script>__md_scope=new URL("../../..",location),__md_hash=e=>[...e].reduce(((e,_)=>(e<<5)-e+_.charCodeAt(0)),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="gainwell" data-md-color-primary="indigo" data-md-color-accent="indigo">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#analgesic_agents_-_opioids" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

<header class="md-header" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href="../../.." title="Ohio SPBM Demo" class="md-header__button md-logo" aria-label="Ohio SPBM Demo" data-md-component="logo">
      
  <img src="../../../img/favicon.ico" alt="logo">

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3zm0 5h18v2H3zm0 5h18v2H3z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Ohio SPBM Demo
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Analgesic Agents - Opioids
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="(prefers-color-scheme: light)" data-md-color-scheme="gainwell" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6m0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4M7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="(prefers-color-scheme: dark)" data-md-color-scheme="slate" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var palette=__md_get("__palette");if(palette&&palette.color){if("(prefers-color-scheme)"===palette.color.media){var media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']");palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent")}for(var[key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" tabindex="0" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
      <div class="md-header__source">
        <a href="https://github.com/gainwell-ohio/spbm/" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><!--! Font Awesome Free 6.6.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc.--><path d="M439.55 236.05 244 40.45a28.87 28.87 0 0 0-40.81 0l-40.66 40.63 51.52 51.52c27.06-9.14 52.68 16.77 43.39 43.68l49.66 49.66c34.23-11.8 61.18 31 35.47 56.69-26.49 26.49-70.21-2.87-56-37.34L240.22 199v121.85c25.3 12.54 22.26 41.85 9.08 55a34.34 34.34 0 0 1-48.55 0c-17.57-17.6-11.07-46.91 11.25-56v-123c-20.8-8.51-24.6-30.74-18.64-45L142.57 101 8.45 235.14a28.86 28.86 0 0 0 0 40.81l195.61 195.6a28.86 28.86 0 0 0 40.8 0l194.69-194.69a28.86 28.86 0 0 0 0-40.81"/></svg>
  </div>
  <div class="md-source__repository">
    Evergreen
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
            
<nav class="md-tabs" aria-label="Tabs" data-md-component="tabs">
  <div class="md-grid">
    <ul class="md-tabs__list">
      
        
  
  
  
    <li class="md-tabs__item">
      <a href="../../.." class="md-tabs__link">
        
  
    
  
  Welcome

      </a>
    </li>
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../../Clinical%20and%20Technical%20Reference%20Guide/peer_to_peer/" class="md-tabs__link">
          
  
  Clinical and Technical Reference Guide

        </a>
      </li>
    
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../../Forms/decision_tree_forms/" class="md-tabs__link">
          
  
  Forms

        </a>
      </li>
    
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../../Learning%20Materials/Access_and_Maintenance/" class="md-tabs__link">
          
  
  Learning Materials

        </a>
      </li>
    
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../../Pharmacist%20Reference%20Guide/Links/" class="md-tabs__link">
          
  
  Pharmacist Reference Guide

        </a>
      </li>
    
  

      
        
  
  
    
  
  
    
    
      <li class="md-tabs__item md-tabs__item--active">
        <a href="../../medical_necessity_policy/" class="md-tabs__link">
          
  
  UPDL and Supporting Documents

        </a>
      </li>
    
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../../Work%20Manager%20Resources/communication_strategies/" class="md-tabs__link">
          
  
  Work Manager Resources

        </a>
      </li>
    
  

      
        
  
  
  
    
    
      <li class="md-tabs__item">
        <a href="../../../about/About/" class="md-tabs__link">
          
  
  About

        </a>
      </li>
    
  

      
    </ul>
  </div>
</nav>
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    


  


<nav class="md-nav md-nav--primary md-nav--lifted" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href="../../.." title="Ohio SPBM Demo" class="md-nav__button md-logo" aria-label="Ohio SPBM Demo" data-md-component="logo">
      
  <img src="../../../img/favicon.ico" alt="logo">

    </a>
    Ohio SPBM Demo
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/gainwell-ohio/spbm/" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><!--! Font Awesome Free 6.6.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc.--><path d="M439.55 236.05 244 40.45a28.87 28.87 0 0 0-40.81 0l-40.66 40.63 51.52 51.52c27.06-9.14 52.68 16.77 43.39 43.68l49.66 49.66c34.23-11.8 61.18 31 35.47 56.69-26.49 26.49-70.21-2.87-56-37.34L240.22 199v121.85c25.3 12.54 22.26 41.85 9.08 55a34.34 34.34 0 0 1-48.55 0c-17.57-17.6-11.07-46.91 11.25-56v-123c-20.8-8.51-24.6-30.74-18.64-45L142.57 101 8.45 235.14a28.86 28.86 0 0 0 0 40.81l195.61 195.6a28.86 28.86 0 0 0 40.8 0l194.69-194.69a28.86 28.86 0 0 0 0-40.81"/></svg>
  </div>
  <div class="md-source__repository">
    Evergreen
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../../.." class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Welcome
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../../Clinical%20and%20Technical%20Reference%20Guide/peer_to_peer/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Clinical and Technical Reference Guide
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

    
      
      
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../../Forms/decision_tree_forms/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Forms
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

    
      
      
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../../Learning%20Materials/Access_and_Maintenance/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Learning Materials
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

    
      
      
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../../Pharmacist%20Reference%20Guide/Links/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Pharmacist Reference Guide
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

    
      
      
  
  
    
  
  
  
    
    
    
      
        
        
      
      
    
    
      
    
    <li class="md-nav__item md-nav__item--active md-nav__item--section md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_6" checked>
        
          
          <label class="md-nav__link" for="__nav_6" id="__nav_6_label" tabindex="">
            
  
  <span class="md-ellipsis">
    UPDL and Supporting Documents
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_6_label" aria-expanded="true">
          <label class="md-nav__title" for="__nav_6">
            <span class="md-nav__icon md-icon"></span>
            UPDL and Supporting Documents
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../medical_necessity_policy/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Medical Necessity Policy and Procedures
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../otc_list/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    OTC List
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Analgesic_Agents/NSAIDs/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Analgesic Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../BloodFCT_Agents/colony_stimulating_factors/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    BloodFCT Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../CNS_Agents/alzheimers_agents/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    CNS Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Cardio_Agents/angina_hypertension/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Cardio Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Derma_Agents/oral_acne_products/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Derma Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Endocrine_Agents/androgens/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Endocrine Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Gastro_Agents/anti-emetics/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Gastro Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Genitourinary_Agents/benign_prostatic_hyperplasia/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Genitourinary Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Immuno_Agents/systematic_inflammatory/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Immuno Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Infectious_Disease_Agents/antifungals/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Infectious Disease Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Ophthalmic_Agents/NSAIDs/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Ophthalmic Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Otic_Agents/antibacterial/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Otic Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Respiratory_Agents/antihistamines/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Respiratory Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Supporting%20Documents/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Supporting Documents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../Topical_Agents/antifungal/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Topical Agents
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

              
            
              
                
  
  
    
  
  
  
    
    
    
      
      
    
    
      
    
    <li class="md-nav__item md-nav__item--active md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_6_18" checked>
        
          
          <label class="md-nav__link" for="__nav_6_18" id="__nav_6_18_label" tabindex="0">
            
  
  <span class="md-ellipsis">
    ePA Question Sets
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_6_18_label" aria-expanded="true">
          <label class="md-nav__title" for="__nav_6_18">
            <span class="md-nav__icon md-icon"></span>
            ePA Question Sets
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../BloodBlood%20Products%20Hematopoietic%20Agents/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Blood Formation, Coagulation, and Thrombosis Agents: Hematopoietic Agents
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../BloodBlood%20Products%20Hemophilia%20Factors/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Blood Formation, Coagulation, and Thrombosis Agents: Hemophilia Factor
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../CNS%20Agents%20Anti-Migraine%20Agents%2C%20Cluster%20Headache/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Central Nervous System (CNS) Agents: Anti-Migraine Agents, Cluster Headache
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../CNS%20Agents%20Anticonvulsants%2C%20Rescue/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Central Nervous System (CNS) Agents - Anticonvulsants Rescue
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../CNS%20Medication%20Assisted%20Treatment%20of%20Opioid%20Addiction%20v2/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    CNS Agents - Medication Assisted Treatment of Opioid Addiction
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../CNS%20Movement%20Disorders/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    CNS Agents - Movement Disorders
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../CNS%20Narcolepsy%20v2/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Central Nervous System (CNS) Agents - Narcolepsy
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../CV%20Agents%20Lipotropics/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Cardiovascular Agents - Lipotropics
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Cardiovascular%20Agents%20Pulmonary%20Arterial%20Hypertension/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Cardiovascular Agents- Pulmonary Arterial Hypertension
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Cerdelga%20%28Type%201%20Gaucher%20disease%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Cerdelga
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Cerezyme%2C%20Elelyso%2C%20Vpriv%20%28Type%201%20Gaucher%20disease%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Cerezyme, Elelyso, Vpriv
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Cubicin%20%28bacterial%20infections%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Cubicin
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Dermatological%20Oral%20Acne%20Products/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Dermatologic Agents - Oral Acne Products
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Emflaza%20%28Duchenne%20muscular%20dystrophy%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Emflaza
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Endocrine%20Agents%20Androgens/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Endocrine Agents - Androgens
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Endocrine%20Agents%20Diabetes%20%E2%80%93%20Insulin/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Endocrine Agents - Diabetes – Insulin
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Endocrine%20Agents%20Diabetes%20%E2%80%93%20Non-Insulin/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Endocrine Agents - Diabetes – Non-Insulin
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Endocrine%20Agents%20Growth%20Hormone/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Endocrine Agents - Growth Hormone**
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Endocrine%20Agents%20Uterine%20Fibroids/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Endocrine Agents - Uterine Fibroids**
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Evrysdi%20%28spinal%20muscular%20atrophy%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Evrysdi
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../ID%20Agents%20Antifungals/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Infectious Disease Agents - Antifungals
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../ID_antibiotics-cephalosporins/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Infectious Disease Agents - Antibiotics – Cephalosporins
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../ID_antibiotics_macrolides/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Infectious Disease Agents - Antibiotics – Macrolides
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../ID_antibiotics%E2%80%93quinolones/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Infectious Disease Agents - Antibiotics – Quinolones
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../ID_antibiotics%E2%80%93tetracyclines/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Infectious Disease Agents: Antibiotics – Tetracyclines
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Immunomodulator%20Agents%20for%20Systemic%20Inflammatory%20Disease/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Immunomodulator Agents for Systemic Inflammatory Disease
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Increlex%20%28growth%20failure%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Increlex
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Infectious%20Disease%20Agents%20Antibiotics%20%E2%80%93%20Inhaled/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Infectious Disease Agents - Antibiotics - Inhaled
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Infectious%20Disease%20Agents%20Antivirals%20%20Hepatitis%20C%20Agents/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Infectious Disease Agents: Antivirals – Hepatitis C Agents
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Korlym%20%28elevated%20cortisol%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Korlym
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Methoxasalen%20%28vitiligo%2C%20psoriasis%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Methoxasalen
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Nuedexta%20%28pseudobulbar%20affect%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Nuedexta
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Omnipod%2C%20V-Go%20%28insulin%20pump%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Omnipod, V-Go
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Oxandrolone%20%28weight%20gain%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Oxandrolone
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Priftin%20%28active%20or%20latent%20TB%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Priftin
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Respiratory%20Agents%20Cystic%20Fibrosis/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Respiratory Agents - Cystic Fibrosis
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Respiratory%20Agents%20Hereditary%20Angioedema/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Respiratory Agents - Hereditary Angioedema
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Respiratory%20Agents%20Monoclonal%20Antibodies-Anti-ILAnti-IgE/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Respiratory Agents - Monoclonal Antibodies-Anti-IL/Anti-IgE
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Revlimid%20%28myelodysplastic%20syndrome%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Thalidomide Analogue - Revlimid (lenalidomide)
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Sandostatin%2C%20Sandostatin%20LAR%20%28acromegaly%2C%20carcinoid%20tumors%2C%20and%20VIPomas%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Sanostatin, Sandostatin LAR
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Signifor%2C%20Signifor%20LAR%20%28Cushing%E2%80%99s%20disease%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Signifor, Signifor LAR
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Sirturo%20%28multi-drug%20resistant%20TB%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Sirturo
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Sivextro%20%28bacterial%20infections%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Sivextro
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Somavert%20%28acromegaly%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Somavert
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Stimate%20%28von%20Willebrand%27s%20disease%2C%20hemophilia%20A%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Stimate
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Synagis%20%28RSV%20prevention%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Synagis
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Targretin%20Capsulesgel%20%28cutaneous%20T-cell%20lymphoma%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Targretin Capsulesgel
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Thalomid%20%28erythema%20nodosum%20leprosum%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Thalomid
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Xanax%20XR%20%28panic%20disorder%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Long-acting Benzodiazepine - Xanax XR
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Zavesca%20%28Type%201%20Gaucher%20disease%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Zavesca
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../Zyvox%20%28bacterial%20infections%29/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Zyvox
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../ablysinol/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Ablysinol
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../acthar/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Acthar
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../aldara/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Aldara
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../analgesic_NSAID/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Analgesic Agents - NSAIDS
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
    
  
  
  
    <li class="md-nav__item md-nav__item--active">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
        
      
      
        <label class="md-nav__link md-nav__link--active" for="__toc">
          
  
  <span class="md-ellipsis">
    Analgesic Agents - Opioids
  </span>
  

          <span class="md-nav__icon md-icon"></span>
        </label>
      
      <a href="./" class="md-nav__link md-nav__link--active">
        
  
  <span class="md-ellipsis">
    Analgesic Agents - Opioids
  </span>
  

      </a>
      
        

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#criteria" class="md-nav__link">
    <span class="md-ellipsis">
      Criteria
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#non-preferred_products_-_short_acting" class="md-nav__link">
    <span class="md-ellipsis">
      Non-Preferred Products - Short Acting
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#non-preferred_products_-_long_acting" class="md-nav__link">
    <span class="md-ellipsis">
      Non-Preferred Products - Long Acting
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#butrans_morphine_sulfate_er_tab_nucynta" class="md-nav__link">
    <span class="md-ellipsis">
      Butrans, Morphine Sulfate ER Tab, Nucynta
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#transmucosal_fentanyl_products" class="md-nav__link">
    <span class="md-ellipsis">
      Transmucosal Fentanyl Products
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#preferred_products_-_short_acting" class="md-nav__link">
    <span class="md-ellipsis">
      Preferred Products - Short Acting
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../blood_oral_anticoagulants/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Blood Formation, Coagulation, and Thrombosis Agents - Oral Anticoagulants
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../blood_oral_antiplatelet/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Blood Formation, Coagulation, and Thrombosis Agents - Oral Antiplatelet
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../blood_products_colony_stimulating/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Blood Formation, Coagulation, and Thrombosis Agents - Colony Stimulating Factors
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../blood_products_heparin-related/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Blood Formation, Coagulation, and Thrombosis Agents - Heparin-Related Preparations
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../cardio_antiarrhythmics/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Cardiovascular Agents - Antiarrhythmics
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../carnitor/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Carnitor
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../cns_alzheimers/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    CNS Agents - Alzheimer’s Agents
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../cns_fibromyalgia/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    CNS - Fibromyalgia
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../cns_multiple_sclerosis/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    CNS Agents - Multiple Sclerosis
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../cns_parkinsons/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    CNS Agents - Parkinson's Agents
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../cns_restless_legs/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    CNS Agents - Restless Legs Syndrome
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../cns_skeletal_muscle_relaxants/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    CNS Agents - Skeletal Muscle Relaxants, Non-Benzodiazepine
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../csn_sedative-hypnotics/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    CNS Agents - Sedative-Hypnotics, Non-Barbiturate
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../cv_angina_hypertension_heart_failure/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    CV Agents - Angina, Hypertension &amp; Heart Failure
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../dermatological_topical_acne/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Dermatologic Agents - Topical Acne Products
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../endocrine_diabetes-hypoglycemia/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Endocrine Agents - Diabetes – Hypoglycemia Treatments
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../endocrine_endometriosis/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Endocrine endometriosis
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../endocrine_estrogenic_agents/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Endocrine Agents - Estrogenic Agents
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../endocrine_osteoporosis-bose_ossification/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Endocrine Agents - Osteoporosis – Bone Ossification Enhancers
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../eye_antibiotic/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Ophthalmic Agents - Antibiotic and Antibiotic-Steroid Combination Drops and Ointments
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../gastro_anti-emetics/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Gastrointestinal Agents - Anti-Emetics
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../gastro_crohns/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Gastrointestinal Agents - Crohn’s Disease
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../gastro_ibs/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Gastrointestinal Agents - Irritable Bowel Syndrome (IBS) with Diarrhea
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../gastro_pancreatic_enzymes/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Gastrointestinal Agents - Pancreatic Enzymes
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../gastro_ulcerative_colitis/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Gastrointestinal Agents - Ulcerative Colitis
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../gastrointestinal_proton_pump_inhibitors/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Gastroinstinal Agents - Proton Pump Inhibitors
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../gastrointestinal_unspecified_GI/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Gastrointestinal Agents - Unspecified GI
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../genitourinary_benign_prostatic_hyperplasia/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Genitourinary Agents - Benign Prostatic Hyperplasia
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../genitourinary_electrolyte_depleter/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Genitourinary Agents - Electrolyte Depleter Agents
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../gu_urinary_antispasmodics/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Genitourinary Agents - Urinary Antispasmodics
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../hetlioz/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Hetlioz
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../infectious_antivirals_herpes/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Infectious Disease Agents - Antivirals – Herpes
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../infectious_disease_antivirals-HIV/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Infectious Disease Agents - Antivirals – HIV
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../nizatidine/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Nizatidine
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../ophthalmic_NSAIDS/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Ophthalmic Agents - NSAIDs
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../ophthalmic_agents_dry_eye_treatments/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Ophthalmic Agents - Dry Eye Treatment
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../ophthalmic_antihistamines/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Ophthalmic Agents - Antihistamines &amp; Mast Cell Stabilizers
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../ophthalmic_glaucoma/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Ophthalmic Agents - Glaucoma Agents
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../ophthalmic_ophthalmic_steroids/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Ophthalmic Agents - Ophthalmic Steroids
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../otic_antibacterial/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Otic Agents - Antibacterial and Antibacterial/Steroid Combination
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../panretin/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Panretin
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../qbrexza/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Qbrexza
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../rectiv/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Rectiv
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../respiratory_antihistamines_second_generation/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Respiratory Agents - Antihistamines-Second Generation
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../respiratory_epinephrine_auto-injectors/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Respiratory Agents - Epinephrine Auto-Injectors
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../respiratory_inhaled_agents/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Respiratory Agents: Inhaled Agents
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../respiratory_leukotriene_receptor_modifiers/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Respiratory Agents - Leukotriene Receptor Modifiers &amp; Inhibitors
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../respiratory_nasal_preparations/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Respiratory Agents - Nasal Preparations
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../respiratory_other/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Respiratory Agents: Other Agents
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../rilutek/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Rilutek
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../topical_antifungals/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Topical Agents - Antifungals
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../topical_antiparasitics/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Topical Agents - Antiparasitics
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../topical_corticosteroids/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Topical Agents - Corticosteroids
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../topical_immunomodulators/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Topical Agents - Immunomodulators
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../zyclara/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Zyclara
  </span>
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../../Work%20Manager%20Resources/communication_strategies/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    Work Manager Resources
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

    
      
      
  
  
  
  
    
    
    
      
      
    
    
      
        
        
      
    
    <li class="md-nav__item md-nav__item--pruned md-nav__item--nested">
      
        
  
  
    <a href="../../../about/About/" class="md-nav__link">
      
  
  <span class="md-ellipsis">
    About
  </span>
  

      
        <span class="md-nav__icon md-icon"></span>
      
    </a>
  

      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#criteria" class="md-nav__link">
    <span class="md-ellipsis">
      Criteria
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#non-preferred_products_-_short_acting" class="md-nav__link">
    <span class="md-ellipsis">
      Non-Preferred Products - Short Acting
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#non-preferred_products_-_long_acting" class="md-nav__link">
    <span class="md-ellipsis">
      Non-Preferred Products - Long Acting
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#butrans_morphine_sulfate_er_tab_nucynta" class="md-nav__link">
    <span class="md-ellipsis">
      Butrans, Morphine Sulfate ER Tab, Nucynta
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#transmucosal_fentanyl_products" class="md-nav__link">
    <span class="md-ellipsis">
      Transmucosal Fentanyl Products
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#preferred_products_-_short_acting" class="md-nav__link">
    <span class="md-ellipsis">
      Preferred Products - Short Acting
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              <article class="md-content__inner md-typeset">
                
                  

  
    <a href="https://github.com/gainwell-ohio/spbm/edit/main/docs/UPDL and Supporting Documents/ePA Question Sets/analgesic_opioids.md" title="Edit this page" class="md-content__button md-icon">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20.71 7.04c.39-.39.39-1.04 0-1.41l-2.34-2.34c-.37-.39-1.02-.39-1.41 0l-1.84 1.83 3.75 3.75M3 17.25V21h3.75L17.81 9.93l-3.75-3.75z"/></svg>
    </a>
  
  


<h1 id="analgesic_agents_-_opioids">Analgesic Agents - Opioids<a class="headerlink" href="#analgesic_agents_-_opioids" title="Permanent link">&para;</a></h1>
<p><a href="https://mygainwell-my.sharepoint.com/:w:/g/personal/kaelyn_dobbins_gainwelltechnologies_com/EavixVJTp-lLrPNk5wnba-EBh0tdXFUKnwnI_Ps6rZodQQ?e=UUzJaQ" rel="&quot;noopener" target="_blank">Criteria Document</a></p>
<h2 id="criteria">Criteria<a class="headerlink" href="#criteria" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr class="header">
<th>Criteria 1   </th>
<th><p>NP Agents – Short Acting Agents- Acetaminophen/Caffeine/Dihydrocodeine, Benzhydrocodone/Acetaminophen,</p>
<p>Butalbital/Acetaminophen/Caffeine/Codeine 50/300/40/30mg, Dsuvia, Hydrocodone/Acetaminophen 5-300, Hydrocodone/Acetaminophen 7.5-300, Hydrocodone/Acetaminophen 10-300mg, Hydrocodone/Ibuprofen, Levorphanol, Meperidine, Methadone, Oxycodone/Ibuprofen, Oxymorphone IR, Pentazocine/Naloxone, Seglentis, Tramadol Sol</p></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Criteria 2</td>
<td>NP Agents – Long Acting/Extended-Release Formulations-Belbuca, Buprenorphine TD Patch Weekly, Fentanyl, Hydrocodone Bitartrate ER 12HR Cap, Hydrocodone Bitartrate ER 24HR Tab, Hydromorphone ER, Morphine ER 24HR Cap, Oxycodone ER, Oxymorphone ER, Tramadol ER, Xtampza ER QL</td>
</tr>
<tr class="even">
<td>Criteria 3</td>
<td>Long Acting Preferred Agents- Butrans (BvG), Morphine ER Tab, Nucynta ER</td>
</tr>
<tr class="odd">
<td>Criteria 4</td>
<td>NP Transmucosal Fentanyl Products</td>
</tr>
<tr class="even">
<td>Criteria 5</td>
<td>Preferred Agents – Short Acting Agents- Acetaminophen/Codeine, Butalbital/Acetaminophen/Caffeine/Codeine, Butalbital/Aspirin/Caffeine/Codeine, Butorphanol, Codeine, Hydrocodone/Acetaminophen, Hydromorphone IR, Morphine IR Tab, Morphine IR Sol, Nucynta IR, Oxycodone Cap, Oxycodone Sol, Oxycodone Tab, Oxycodone/Acetaminophen, Tramadol, Tramadol/Acetaminophen</td>
</tr>
</tbody>
</table>

<h2 id="non-preferred_products_-_short_acting">Non-Preferred Products - Short Acting<a class="headerlink" href="#non-preferred_products_-_short_acting" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Analgesic Agents: Opioids</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Non-Preferred Products- Short Acting</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>ACETAMINOPHEN/CAFFEINE/DIHYDROCODEINE</td>
<td>073169</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BENZHYDROCODONE/ACETAMINOPHEN</td>
<td>078222</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BENZHYDROCODONE/ACETAMINOPHEN</td>
<td>079488</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BENZHYDROCODONE/ACETAMINOPHEN</td>
<td>079489</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BUTALBITAL/ACETAMINOPHEN/CAFFEINE/CODEINE 50/300/40/30 mg</td>
<td>071253</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>DSUVIA</td>
<td>079437</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN 5-300, 7.5-300 and 10-300 mg</td>
<td>057726</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN 5-300, 7.5-300 and 10-300 mg</td>
<td>060338</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN 5-300, 7.5-300 and 10-300 mg</td>
<td>060533</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE/IBUPROFEN</td>
<td>034068</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE/IBUPROFEN</td>
<td>054674</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE/IBUPROFEN</td>
<td>063650</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>LEVORPHANOL</td>
<td>004228</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>LEVORPHANOL</td>
<td>079449</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MEPERIDINE</td>
<td>004049</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MEPERIDINE</td>
<td>004051</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MEPERIDINE</td>
<td>004053</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MEPERIDINE</td>
<td>059787</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MEPERIDINE</td>
<td>059790</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MEPERIDINE</td>
<td>059792</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MEPERIDINE</td>
<td>059793</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MEPERIDINE</td>
<td>059794</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MEPERIDINE</td>
<td>059797</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MEPERIDINE</td>
<td>059804</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MEPERIDINE</td>
<td>078735</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MEPERIDINE</td>
<td>078736</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MEPERIDINE</td>
<td>079737</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>METHADONE</td>
<td>004235</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>METHADONE</td>
<td>004237</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>METHADONE</td>
<td>004238</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>METHADONE</td>
<td>004239</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>METHADONE</td>
<td>004240</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>METHADONE</td>
<td>004242</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>METHADONE</td>
<td>023767</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>METHADONE</td>
<td>082101</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE/IBUPROFEN</td>
<td>058402</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYMORPHONE IR</td>
<td>061086</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYMORPHONE IR</td>
<td>061087</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>PENTAZOCINE/NALOXONE</td>
<td>004292</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>SEGLENTIS</td>
<td>082830</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>TRAMADOL SOL</td>
<td>081474</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number </strong></th>
<th><strong>Question ID </strong></th>
<th><strong>Default Next Question ID </strong></th>
<th><strong>Question Type </strong></th>
<th><strong>Question Text </strong></th>
<th><strong>Choice Text </strong></th>
<th><strong>Next Question ID </strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>0009</td>
<td></td>
<td>Select and Free Text</td>
<td>Is the patient new to (initial request) or continuing therapy with the requested product (re-authorization request)?</td>
<td>Initial request for product </td>
<td>0010</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1001</td>
</tr>
<tr class="odd">
<td>2</td>
<td>0010</td>
<td></td>
<td>Select </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?  </td>
<td>Y</td>
<td>0011</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>3</td>
<td>0011</td>
<td></td>
<td>Select</td>
<td><p>Does this request exceed 30 MED AND/OR exceed a 7 days supply (or 5 days supply if &lt;18 years old)?</p>
<p>Patients with initial prescriptions for opioid therapy, defined as no rx opioid claims in the last 90 days, will be limited to 30 MED per day and a maximum of 7 days (or 5 days supply if &lt;18 years old) per prescription.</p></td>
<td>Y</td>
<td>0012</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0013</td>
</tr>
<tr class="odd">
<td>4</td>
<td>0012</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation to support the need for exceeding 30 MED per day and/or a maximum of 7 days (or 5 days supply if &lt;18 years old) per prescription?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>0013</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>5</td>
<td>0013</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">7 days</span> of at least <span class="underline">two unrelated</span> preferred drugs of the same duration of action (SHORT-ACTING)?</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y</td>
<td>0015</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0014</td>
</tr>
<tr class="odd">
<td>6</td>
<td>0014</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use. </p></td>
<td>Y</td>
<td>0015</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1236</td>
</tr>
<tr class="odd">
<td>7 </td>
<td>0015</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>0016</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0017</td>
</tr>
<tr class="odd">
<td>8</td>
<td>0016</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>0017</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>9</td>
<td>0017</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Does the patient meet one of the following exemptions?</p>
<p>1) Diagnosis of active cancer treatment, palliative care, end-of-life/hospice care, sickle cell, severe burn, traumatic crushing of tissue, amputation, major orthopedic surgery </p>
<p>2) Prescriber attestation that patient is not opioid naïve (i.e., new to Medicaid or was on higher dose in hospital)</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0018</td>
</tr>
<tr class="odd">
<td>10</td>
<td>0018</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>1) Diagnosis code which must be for somatic type pain</p>
<p>2) Prescriber attestation that the benefits and risks of opioid therapy has been discussed with patient</p></td>
<td>Y</td>
<td>0019</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>11</td>
<td>0019</td>
<td></td>
<td>Select</td>
<td>Does the provider attest that OARRS has been reviewed before initially prescribing or personally furnishing any controlled substance?</td>
<td>Y </td>
<td>0020</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>12</td>
<td>0020</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of the patient’s indication, previous utilization, and requested length of therapy?</td>
<td>Y</td>
<td>0021</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>13</td>
<td>0021</td>
<td></td>
<td>Select</td>
<td>Initial short-acting requests can be authorized up to 90 days. Does this request meet this requirement?</td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>14</td>
<td>1001</td>
<td></td>
<td>Select</td>
<td>Is the request for a dose escalation?</td>
<td>Y </td>
<td>1002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1005</td>
</tr>
<tr class="odd">
<td>15</td>
<td>1002</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>Prescriber attestation that dose escalation is likely to result in improved function or pain control.</p></td>
<td>Y </td>
<td>1003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>16</td>
<td>1003</td>
<td></td>
<td>Select</td>
<td>Is the request for a cumulative daily dose greater than 80 MED?</td>
<td>Y </td>
<td>1004</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1005</td>
</tr>
<tr class="odd">
<td>17</td>
<td>1004</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is the medication being prescribed by or in consultation with a pain specialist, specialist in the area of the body affected by pain, or anesthesiologist?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y </td>
<td>1005</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>18</td>
<td>1005</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>1) Current treatment plan</p>
<p>2) Demonstrated adherence to treatment plan through progress notes, including pain and function scores, random urine screenings results reviewed, concerns addressed, and no serious adverse outcomes observed</p></td>
<td>Y</td>
<td>1006</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>19</td>
<td>1006</td>
<td></td>
<td>Select</td>
<td>Subsequent short-acting and dose escalation requests can be authorized up to 180 days. Does this request meet this requirement?</td>
<td>Y</td>
<td>END (Pending Manual Review) </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>20</td>
<td>1235 </td>
<td> </td>
<td>Free Text </td>
<td>Please provide the rationale for the medication, dose, and duration being requested.  </td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
<tr class="even">
<td>21</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
</tbody>
</table>

<p>LENGTH OF AUTHORIZATIONS: For the course of therapy, up to 180 days.
Initial short-acting and long-acting requests may only be authorized for
up to 90 days.</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>**Last Approved **</td>
<td>9/21/2023</td>
</tr>
<tr>
<td><strong>Other</strong></td>
<td></td>
</tr>
</tbody>
</table>
<h2 id="non-preferred_products_-_long_acting">Non-Preferred Products - Long Acting<a class="headerlink" href="#non-preferred_products_-_long_acting" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Analgesic Agents: Opioids</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Non-Preferred Products- Long Acting</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>BELBUCA</td>
<td>075050</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BELBUCA</td>
<td>075051</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BELBUCA</td>
<td>075052</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BELBUCA</td>
<td>075053</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BELBUCA</td>
<td>075054</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BELBUCA</td>
<td>075055</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BELBUCA</td>
<td>075056</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BUPRENORPHINE TD PATCH WEEKLY</td>
<td>059589</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BUPRENORPHINE TD PATCH WEEKLY</td>
<td>059590</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BUPRENORPHINE TD PATCH WEEKLY</td>
<td>059591</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BUPRENORPHINE TD PATCH WEEKLY</td>
<td>071432</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BUPRENORPHINE TD PATCH WEEKLY</td>
<td>072673</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FENTANYL 25 MCG/HR PATCH</td>
<td>015880</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FENTANYL 50 MCG/HR PATCH</td>
<td>015881</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FENTANYL 75 MCG/HR PATCH</td>
<td>015882</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FENTANYL 100 MCG/HR PATCH</td>
<td>015883</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FENTANYL 12 MCG/HR PATCH</td>
<td>059102</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FENTANYL 62.5 MCG/HR PATCH</td>
<td>073524</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FENTANYL 87.5 MCG/HR PATCH</td>
<td>073525</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FENTANYL 37.5 MCG/HR PATCH</td>
<td>073532</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE BITARTRATE ER 12 HR CAP</td>
<td>073621</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE BITARTRATE ER 12 HR CAP</td>
<td>073622</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE BITARTRATE ER 12 HR CAP</td>
<td>073623</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE BITARTRATE ER 12 HR CAP</td>
<td>073624</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE BITARTRATE ER 12 HR CAP</td>
<td>073625</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE BITARTRATE ER 12 HR CAP</td>
<td>073626</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE BITARTRATE ER 24HR TAB</td>
<td>073176</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE BITARTRATE ER 24HR TAB</td>
<td>073177</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE BITARTRATE ER 24HR TAB</td>
<td>073179</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE BITARTRATE ER 24HR TAB</td>
<td>073180</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE BITARTRATE ER 24HR TAB</td>
<td>073181</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE BITARTRATE ER 24HR TAB</td>
<td>073182</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE BITARTRATE ER 24HR TAB</td>
<td>073183</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROMORPHONE ER</td>
<td>066200</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROMORPHONE ER</td>
<td>069860</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROMORPHONE ER</td>
<td>069889</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROMORPHONE ER</td>
<td>069890</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>050220</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>050221</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>050222</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>064739</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>064740</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>050219</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>060355</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>060356</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>060357</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>060358</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>061722</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>061748</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>061749</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE ER 24HR CAP</td>
<td>062358</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE ER</td>
<td>072862</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE ER</td>
<td>072863</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE ER</td>
<td>072864</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE ER</td>
<td>072865</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE ER</td>
<td>072866</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE ER</td>
<td>072867</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE ER</td>
<td>072868</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYMORPHONE ER</td>
<td>061091</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYMORPHONE ER</td>
<td>061092</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYMORPHONE ER</td>
<td>061093</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYMORPHONE ER</td>
<td>061094</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYMORPHONE ER</td>
<td>063782</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYMORPHONE ER</td>
<td>063783</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYMORPHONE ER</td>
<td>063784</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>TRAMADOL ER</td>
<td>043536</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>TRAMADOL ER</td>
<td>043537</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>TRAMADOL ER</td>
<td>060274</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>TRAMADOL ER</td>
<td>063422</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>TRAMADOL ER</td>
<td>063423</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>TRAMADOL ER</td>
<td>063424</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>TRAMADOL ER</td>
<td>067760</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>TRAMADOL ER</td>
<td>067761</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>TRAMADOL ER</td>
<td>067762</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>XTAMPZA ER</td>
<td>076031</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>XTAMPZA ER</td>
<td>076032</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>XTAMPZA ER</td>
<td>076033</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>XTAMPZA ER</td>
<td>076034</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>XTAMPZA ER</td>
<td>076035</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number </strong></th>
<th><strong>Question ID </strong></th>
<th><strong>Default Next Question ID </strong></th>
<th><strong>Question Type </strong></th>
<th><strong>Question Text </strong></th>
<th><strong>Choice Text </strong></th>
<th><strong>Next Question ID </strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>0001</td>
<td></td>
<td>Select and Free Text</td>
<td>Is the patient new to (initial request) or continuing therapy with the requested product (re-authorization request)?</td>
<td>Initial request for product </td>
<td>0002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)</td>
<td>1001</td>
</tr>
<tr class="odd">
<td>2</td>
<td>0002</td>
<td></td>
<td>Select </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?  </td>
<td>Y</td>
<td>0003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>3</td>
<td>0003</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following products:</p>
<p>Buprenorphine TD Patch Weekly (generic Butrans), Morphine ER 24HR Cap (generic Kadian)</p></td>
<td>Y</td>
<td>0004</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0009</td>
</tr>
<tr class="odd">
<td>4</td>
<td>0004</td>
<td></td>
<td>Select</td>
<td>What product is being requested?</td>
<td>Buprenorphine TD Patch Weekly (generic Butrans)</td>
<td>0005</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Morphine ER 24HR Cap (generic Kadian)</td>
<td>0007</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Other</td>
<td>0009</td>
</tr>
<tr class="even">
<td>5</td>
<td>0005</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the brand medication been attempted and failed or is the brand medication contraindicated?  </p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>0006</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>6</td>
<td>0006</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation for doses greater than 5mcg/hour an inadequate clinical response with at least one opioid formulation taken for at least 60 of the last 90 days?</td>
<td>Y</td>
<td>0009</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>7</td>
<td>0007</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is this request being used for cancer pain, palliative care, or end-of-life/hospice care?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>0009</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0008</td>
</tr>
<tr class="even">
<td>8</td>
<td>0008</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of an inadequate clinical response of at least <span class="underline">one</span> opioid formulation taken for at least 60 of the last 90 days?</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y</td>
<td>0009</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>9</td>
<td>0009</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">7 days</span> of at least <span class="underline">two unrelated</span> preferred drugs of the same duration of action (LONG-ACTING)?</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y</td>
<td>0011</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0010</td>
</tr>
<tr class="even">
<td>10</td>
<td>0010</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use. </p></td>
<td>Y</td>
<td>0011</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1236</td>
</tr>
<tr class="even">
<td>11</td>
<td>0011</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>0012</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0013</td>
</tr>
<tr class="even">
<td>12</td>
<td>0012</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>0013</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>13</td>
<td>0013</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Does the patient meet the following exemption?</p>
<p>Patient is receiving long-acting opioids for cancer pain, palliative care, or end-of-life hospice care</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0014</td>
</tr>
<tr class="even">
<td>14</td>
<td>0014</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<ol type="1">
<li><p>Request is a daily dose equivalent of less than or equal to 80 MED</p></li>
<li><p>Inadequate clinical response to both non-opioid pharmacologic and non-pharmacologic treatments</p></li>
<li><p>Current use of opioids for greater than or equal to 60 of the last 90 days</p></li>
<li><p>Treatment plan including risk assessment, substance abuse history, concurrent therapies, and requirements for random urine screenings (baseline urine drug tests must be submitted)</p></li>
<li><p>Pain and function scores at each visit</p></li>
<li><p>Opioid contract required to be in place and submitted with PA form</p></li>
</ol></td>
<td>Y</td>
<td>0015</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>15</td>
<td>0015</td>
<td></td>
<td>Select</td>
<td>Does the provider attest that OARRS has been reviewed before initially prescribing or personally furnishing any controlled substance?</td>
<td>Y</td>
<td>0016</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>16</td>
<td>0016</td>
<td></td>
<td>Select</td>
<td>Initial long-acting requests can be authorized up to 90 days. Does this request meet this requirement?</td>
<td>Y </td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="even">
<td>17</td>
<td>1001</td>
<td></td>
<td>Select</td>
<td>Is the request for a dose escalation?</td>
<td>Y </td>
<td>1002</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1005</td>
</tr>
<tr class="even">
<td>18</td>
<td>1002</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>Prescriber attestation that dose escalation is likely to result in improved function or pain control.</p></td>
<td>Y </td>
<td>1003</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="even">
<td>19</td>
<td>1003</td>
<td></td>
<td>Select</td>
<td>Is the request for a cumulative daily dose greater than 80 MED?</td>
<td>Y </td>
<td>1004</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1005</td>
</tr>
<tr class="even">
<td>20</td>
<td>1004</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is the medication being prescribed by or in consultation with a pain specialist, specialist in the area of the body affected by pain, or anesthesiologist?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y </td>
<td>1005</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="even">
<td>21</td>
<td>1005</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>1) Current treatment plan</p>
<p>2) Demonstrated adherence to treatment plan through progress notes, including pain and function scores, random urine screenings results reviewed, concerns addressed, and no serious adverse outcomes observed</p></td>
<td>Y</td>
<td>1006</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>22</td>
<td>1006</td>
<td></td>
<td>Select</td>
<td>Subsequent long-acting and dose escalation requests can be authorized up to 180 days. Does this request meet this requirement?</td>
<td>Y </td>
<td>END (Pending Manual Review) </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="even">
<td>23</td>
<td>1235 </td>
<td> </td>
<td>Free Text </td>
<td>Please provide the rationale for the medication, dose, and duration being requested.  </td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
<tr class="odd">
<td>24</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
</tbody>
</table>

<p>LENGTH OF AUTHORIZATIONS: For the course of therapy, up to 180 days.
Initial short-acting and long-acting requests may only be authorized for
up to 90 days.</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>**Last Approved **</td>
<td>9/21/2023</td>
</tr>
<tr>
<td><strong>Other</strong></td>
<td></td>
</tr>
</tbody>
</table>
<h2 id="butrans_morphine_sulfate_er_tab_nucynta">Butrans, Morphine Sulfate ER Tab, Nucynta<a class="headerlink" href="#butrans_morphine_sulfate_er_tab_nucynta" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Analgesic Agents: Opioids</th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Butrans, Morphine Sulfate ER Tab, Nucynta</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th>X</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td></td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td>BUTRANS</td>
<td>059589</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td>BUTRANS</td>
<td>059590</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td>BUTRANS</td>
<td>059591</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td>BUTRANS</td>
<td>071432</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td>BUTRANS</td>
<td>072673</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE ER TAB</td>
<td>004096</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE ER TAB</td>
<td>004097</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE ER TAB</td>
<td>011886</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE ER TAB</td>
<td>011887</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE ER TAB</td>
<td>016522</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td>NUCYNTA ER</td>
<td>067266</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td>NUCYNTA ER</td>
<td>067267</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td>NUCYNTA ER</td>
<td>067268</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td></td>
<td>NUCYNTA ER</td>
<td>067270</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td></td>
<td>NUCYNTA ER</td>
<td>067271</td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><strong>Sequence Number </strong></td>
<td><strong>Question ID </strong></td>
<td><strong>Default Next Question ID </strong></td>
<td><strong>Question Type </strong></td>
<td><strong>Question Text </strong></td>
<td><strong>Choice Text </strong></td>
<td><strong>Next Question ID </strong></td>
</tr>
<tr class="even">
<td>1</td>
<td>0001</td>
<td></td>
<td>Select and Free Text</td>
<td>Is the patient new to (initial request) or continuing therapy with the requested product (re-authorization request)?</td>
<td>Initial request for product </td>
<td>0002</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1001</td>
</tr>
<tr class="even">
<td>2</td>
<td>0002</td>
<td></td>
<td>Select </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling? </td>
<td>Y</td>
<td>0003</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>3</td>
<td>0003</td>
<td></td>
<td>Select</td>
<td>What product is being requested?</td>
<td>Butrans</td>
<td>0004</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Morphine Sulfate ER Tab (generic MS Contin)</td>
<td>0005</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Nucynta ER</td>
<td>0005</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Other</td>
<td>0007</td>
</tr>
<tr class="even">
<td>4</td>
<td>0004</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation for doses greater than 5mcg/hour an inadequate clinical response with at least one opioid formulation taken for at least 60 of the last 90 days?</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>5</td>
<td>0005</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is this request being used for cancer pain, palliative care, or end-of-life/hospice care?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0006</td>
</tr>
<tr class="even">
<td>6</td>
<td>0006</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of an inadequate clinical response of at least <span class="underline">one</span> opioid formulation taken for at least 60 of the last 90 days?</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y</td>
<td>0007</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>7</td>
<td>0007</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Does the patient meet the following exemption?</p>
<p>Patient is receiving long-acting opioids for cancer pain, palliative care, or end-of-life/hospice care.</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0008</td>
</tr>
<tr class="even">
<td>8</td>
<td>0008</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>1) Request is a daily dose equivalent of less than or equal to 80 MED</p>
<p>2) Inadequate clinical response to both non-opioid pharmacologic and non-pharmacologic treatments</p>
<p>3) Current use of opioids for greater than or equal to 60 of the last 90 days</p>
<p>4) Treatment plan including risk assessment, substance abuse history, concurrent therapies, and requirements for random urine screenings (baseline urine drug tests must be submitted)</p>
<p>5) Pain and function scores at each visit</p>
<p>6) Opioid contract required to be in place and submitted with PA form</p></td>
<td>Y</td>
<td>0009</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>9</td>
<td>0009</td>
<td></td>
<td>Select</td>
<td>Does the provider attest that OARRS has been reviewed before initially prescribing or personally furnishing any controlled substance?</td>
<td>Y</td>
<td>0010</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>10</td>
<td>0010</td>
<td></td>
<td>Select</td>
<td>Initial long-acting requests can be authorized up to 90 days. Does this request meet this requirement?</td>
<td>Y </td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="even">
<td>11</td>
<td>1001</td>
<td></td>
<td>Select</td>
<td>Is the request for a dose escalation?</td>
<td>Y </td>
<td>1002</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1005</td>
</tr>
<tr class="even">
<td>12</td>
<td>1002</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>Prescriber attestation that dose escalation is likely to result in improved function or pain control.</p></td>
<td>Y </td>
<td>1003</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="even">
<td>13</td>
<td>1003</td>
<td></td>
<td>Select</td>
<td>Is the request for a cumulative daily dose greater than 80 MED?</td>
<td>Y </td>
<td>1004</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1005</td>
</tr>
<tr class="even">
<td>14</td>
<td>1004</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is the medication being prescribed by or in consultation with a pain specialist, specialist in the area of the body affected by pain, or anesthesiologist?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y </td>
<td>1005</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="even">
<td>15</td>
<td>1005</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>1) Current treatment plan</p>
<p>2) Demonstrated adherence to treatment plan through progress notes, including pain and function scores, random urine screenings results reviewed, concerns addressed, and no serious adverse outcomes observed</p></td>
<td>Y</td>
<td>1006</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>16</td>
<td>1006</td>
<td></td>
<td>Select</td>
<td>Subsequent long-acting and dose escalation requests can be authorized up to 180 days. Does this request meet this requirement?</td>
<td>Y </td>
<td>END (Pending Manual Review) </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="even">
<td>17</td>
<td>1235 </td>
<td> </td>
<td>Free Text </td>
<td>Please provide the rationale for the medication, dose, and duration being requested.  </td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
</tbody>
</table>

<p>LENGTH OF AUTHORIZATIONS: For the course of therapy, up to 180 days.
Initial short-acting and long-acting requests may only be authorized for
up to 90 days.</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>**Last Approved **</td>
<td>9/21/2023</td>
</tr>
<tr>
<td><strong>Other</strong></td>
<td></td>
</tr>
</tbody>
</table>
<h2 id="transmucosal_fentanyl_products">Transmucosal Fentanyl Products<a class="headerlink" href="#transmucosal_fentanyl_products" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Analgesic Agents: Opioids</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Transmucosal Fentanyl Products</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>FENTANYL CITRATE OTFC 200 MCG</td>
<td>022358</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FENTANYL CITRATE OTFC 400 MCG</td>
<td>022360</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FENTANYL CITRATE OTFC 600 MCG</td>
<td>041339</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FENTANYL CITRATE OTFC 800 MCG</td>
<td>041340</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FENTANYL CIT OTFC 1,200 MCG</td>
<td>041341</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FENTANYL CIT OTFC 1,600 MCG</td>
<td>041342</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FENTANYL CIT 100 MCG BUCCAL TB</td>
<td>061492</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FENTANYL CIT 200 MCG BUCCAL TB</td>
<td>061493</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FENTANYL CIT 400 MCG BUCCAL TB</td>
<td>061495</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FENTANYL CIT 600 MCG BUCCAL TB</td>
<td>061496</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>FENTANYL CIT 800 MCG BUCCAL TB</td>
<td>061497</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>SUBSYS 100 MCG SPRAY</td>
<td>068412</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>SUBSYS 400 MCG SPRAY</td>
<td>068413</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>SUBSYS 200 MCG SPRAY</td>
<td>068414</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>SUBSYS 600 MCG SPRAY</td>
<td>068415</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>SUBSYS 800 MCG SPRAY</td>
<td>068416</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>SUBSYS 1200 MCG SPRAY</td>
<td>068756</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>SUBSYS 1600 MCG SPRAY</td>
<td>068757</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number </strong></th>
<th><strong>Question ID </strong></th>
<th><strong>Default Next Question ID </strong></th>
<th><strong>Question Type </strong></th>
<th><strong>Question Text </strong></th>
<th><strong>Choice Text </strong></th>
<th><strong>Next Question ID </strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>0009</td>
<td></td>
<td>Select and Free Text</td>
<td>Is the patient new to (initial request) or continuing therapy with the requested product (re-authorization request)?</td>
<td>Initial request for product </td>
<td>0010</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1001</td>
</tr>
<tr class="odd">
<td>2</td>
<td>0010</td>
<td></td>
<td>Select </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?  </td>
<td>Y</td>
<td>0011</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>3</td>
<td>0011</td>
<td></td>
<td>Select</td>
<td><p>Does this request exceed 30 MED AND/OR exceed a 7 days (or 5 days supply if &lt;18 years old) supply?</p>
<p>Patients with initial prescriptions for opioid therapy, defined as no rx opioid claims in the last 90 days, will be limited to 30 MED per day and a maximum of 7 days (or 5 days supply if &lt;18 years old) per prescription.</p></td>
<td>Y</td>
<td>0012</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0013</td>
</tr>
<tr class="odd">
<td>4</td>
<td>0012</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation to support the need for exceeding 30 MED per day and/or a maximum of 7 days (or 5 days supply if &lt;18 years old) per prescription?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>0013</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>5</td>
<td>0013</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">7 days</span> of at least <span class="underline">two unrelated</span> preferred drugs of the same duration of action (SHORT-ACTING)?</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y</td>
<td>0015</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0014</td>
</tr>
<tr class="odd">
<td>6</td>
<td>0014</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use. </p></td>
<td>Y</td>
<td>0015</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1236</td>
</tr>
<tr class="odd">
<td>7 </td>
<td>0015</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>0016</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0017</td>
</tr>
<tr class="odd">
<td>8</td>
<td>0016</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>0017</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>9</td>
<td>0017</td>
<td></td>
<td>Select</td>
<td>Is the medication being prescribed by an oncologist, pain specialist, or hospice/palliative prescriber?</td>
<td>Y</td>
<td>0018</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>10</td>
<td>0018</td>
<td></td>
<td>Select</td>
<td><p>Is the patient concurrently taking a long-acting opioid at a therapeutic dose of any of the following for at least <span class="underline">7 days</span> without adequate pain relief:</p>
<ol type="1">
<li><p>Greater than or equal to 60 mg oral morphine/day</p></li>
<li><p>Greater than or equal to 8 mg oral hydromorphone/day</p></li>
<li><p>Greater than or equal to 25 mcg/hr transdermal fentanyl</p></li>
<li><p>Greater than or equal to 25 mg oral oxymorphone/day</p></li>
<li><p>Greater than or equal to 30 mg oral oxycodone/day</p></li>
<li><p>Equianalgesic dose of another opioid</p></li>
</ol></td>
<td>Y</td>
<td>0019</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>11</td>
<td>0019</td>
<td></td>
<td>Select</td>
<td>Ohio Medicaid covers up to 4 doses per day for Transmucosal Fentanyl. Does this request meet this requirement?</td>
<td>Y</td>
<td>0020</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1237</td>
</tr>
<tr class="odd">
<td>12</td>
<td>0020</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Does the patient meet one of the following exemptions?</p>
<ol type="1">
<li><p>Diagnosis of active cancer treatment, palliative care, end-of-life/hospice care, sickle cell, severe burn, traumatic crushing of tissue, amputation, major orthopedic surgery </p></li>
<li><p>Prescriber attestation that patient is not opioid naïve (i.e., new to Medicaid or was on higher dose in hospital)</p></li>
</ol>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0021</td>
</tr>
<tr class="odd">
<td>13</td>
<td>0021</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>1) Diagnosis code which must be for somatic type pain</p>
<p>2) Prescriber attestation that the benefits and risks of opioid therapy has been discussed with patient</p></td>
<td>Y</td>
<td>0022</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>14</td>
<td>0022</td>
<td></td>
<td>Select</td>
<td>Does the provider attest that OARRS has been reviewed before initially prescribing or personally furnishing any controlled substance?</td>
<td>Y</td>
<td>0023</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>15</td>
<td>0023</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of the patient’s indication, previous utilization, and requested length of therapy?</td>
<td>Y </td>
<td>0024</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>16</td>
<td>0024</td>
<td></td>
<td>Select</td>
<td>Initial short-acting requests can be authorized up to 90 days. Does this request meet this requirement?</td>
<td>Y </td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>17</td>
<td>1001</td>
<td></td>
<td>Select</td>
<td>Is the request for a dose escalation?</td>
<td>Y </td>
<td>1002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1005</td>
</tr>
<tr class="odd">
<td>18</td>
<td>1002</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>Prescriber attestation that dose escalation is likely to result in improved function or pain control.</p></td>
<td>Y </td>
<td>1003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>19</td>
<td>1003</td>
<td></td>
<td>Select</td>
<td>Is the request for a cumulative daily dose greater than 80 MED?</td>
<td>Y </td>
<td>1004</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1005</td>
</tr>
<tr class="odd">
<td>20</td>
<td>1004</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is the medication being prescribed by or in consultation with a pain specialist, specialist in the area of the body affected by pain, or anesthesiologist?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y </td>
<td>1005</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>21</td>
<td>1005</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>1) Current treatment plan</p>
<p>2) Demonstrated adherence to treatment plan through progress notes, including pain and function scores, random urine screenings results reviewed, concerns addressed, and no serious adverse outcomes observed</p></td>
<td>Y </td>
<td>1006</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>22</td>
<td>1006</td>
<td></td>
<td>Select</td>
<td>Subsequent short-acting and dose escalation requests can be authorized up to 180 days. Does this request meet this requirement?</td>
<td>Y</td>
<td>END (Pending Manual Review) </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>23</td>
<td>1235 </td>
<td> </td>
<td>Free Text </td>
<td>Please provide the rationale for the medication, dose, and duration being requested.  </td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
<tr class="even">
<td>24</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
<tr class="odd">
<td>25</td>
<td>1237</td>
<td></td>
<td>Free Text</td>
<td>Please provide the rationale for the dose and frequency being requested.</td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
</tbody>
</table>

<p>LENGTH OF AUTHORIZATIONS: For the course of therapy, up to 180 days.
Initial short-acting and long-acting requests may only be authorized for
up to 90 days.</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>**Last Approved **</td>
<td>9/21/2023</td>
</tr>
<tr>
<td><strong>Other</strong></td>
<td></td>
</tr>
</tbody>
</table>
<h2 id="preferred_products_-_short_acting">Preferred Products - Short Acting<a class="headerlink" href="#preferred_products_-_short_acting" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong> </th>
<th>Analgesic Agents: Opioids</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong> </td>
<td>Preferred Products- Short Acting</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong> </td>
<td>GCNSeqNo </td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products </strong> </p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th>X</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td></td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name  </td>
<td>Corresponding Code (s) </td>
<td>Type of Code (GCNSeqNo, HICL, NDC) </td>
</tr>
<tr class="even">
<td></td>
<td>ACETAMINOPHEN/CODEINE</td>
<td>004163</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ACETAMINOPHEN/CODEINE</td>
<td>004165</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ACETAMINOPHEN/CODEINE</td>
<td>004169</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ACETAMINOPHEN/CODEINE</td>
<td>045155</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ACETAMINOPHEN/CODEINE</td>
<td>070212</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ACETAMINOPHEN/CODEINE</td>
<td>070224</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BUTALBITAL/ACETAMINOPHEN/CAFFEINE/CODEINE</td>
<td>004149</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BUTALBITAL/ACETAMINOPHEN/CAFFEINE/CODEINE</td>
<td>071253</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BUTALBITAL/ASPIRIN/CAFFEINE/CODEINE</td>
<td>004120</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BUTORPHANOL</td>
<td>004287</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>BUTORPHANOL</td>
<td>004288</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>BUTORPHANOL</td>
<td>016674</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>CODEINE</td>
<td>004185</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>CODEINE</td>
<td>004186</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>CODEINE</td>
<td>004187</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN</td>
<td>030623</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN</td>
<td>047430</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN</td>
<td>047431</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN</td>
<td>053582</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN</td>
<td>066836</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN</td>
<td>068600</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN</td>
<td>071384</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROCODONE/ACETAMINOPHEN</td>
<td>071385</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROMORPHONE IR</td>
<td>004110</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROMORPHONE IR</td>
<td>004112</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROMORPHONE IR</td>
<td>015190</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>HYDROMORPHONE IR</td>
<td>016156</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>HYDROMORPHONE IR</td>
<td>004108</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE IR TAB, SOL</td>
<td>004087</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE IR TAB, SOL</td>
<td>004089</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE IR TAB, SOL</td>
<td>004090</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE IR TAB, SOL</td>
<td>004091</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MORPHINE IR TAB, SOL</td>
<td>004092</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MORPHINE IR TAB, SOL</td>
<td>071396</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>NUCYNTA IR 50 MG TAB</td>
<td>065319</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>NUCYNTA IR 75 MG TAB</td>
<td>065320</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>NUCYNTA IR 100 MG TAB</td>
<td>065321</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>004224</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>004225</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>013467</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>015065</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>024507</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>045298</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>046474</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>046475</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>069101</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>076361</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>078532</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE CAP, SOL, TAB</td>
<td>078533</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE/ACETAMINOPHEN</td>
<td>004221</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE/ACETAMINOPHEN</td>
<td>004222</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE/ACETAMINOPHEN</td>
<td>013998</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>OXYCODONE/ACETAMINOPHEN</td>
<td>048976</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>OXYCODONE/ACETAMINOPHEN</td>
<td>048977</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>TRAMADOL</td>
<td>023139</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>TRAMADOL</td>
<td>044978</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>TRAMADOL/ACETAMINOPHEN</td>
<td>048456</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number </strong></th>
<th><strong>Question ID </strong></th>
<th><strong>Default Next Question ID </strong></th>
<th><strong>Question Type </strong></th>
<th><strong>Question Text </strong></th>
<th><strong>Choice Text </strong></th>
<th><strong>Next Question ID </strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>0009</td>
<td></td>
<td>Select and Free Text</td>
<td>Is the patient new to (initial request) or continuing therapy with the requested product (re-authorization request)?</td>
<td>Initial request for product </td>
<td>0010</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)  </td>
<td>1001</td>
</tr>
<tr class="odd">
<td>2</td>
<td>0010</td>
<td></td>
<td>Select </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?  </td>
<td>Y</td>
<td>0011</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>3</td>
<td>0011</td>
<td></td>
<td>Select</td>
<td><p>Does this request exceed 30 MED AND/OR exceed a 7 days supply (or 5 days supply if &lt;18 years old)?</p>
<p>Patients with initial prescriptions for opioid therapy, defined as no rx opioid claims in the last 90 days, will be limited to 30 MED per day and a maximum of 7 days (or 5 days supply if &lt;18 years old) per prescription.</p></td>
<td>Y</td>
<td>0012</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1237</td>
</tr>
<tr class="odd">
<td>4</td>
<td>0012</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation to support the need for exceeding 30 MED per day and/or a maximum of 7 days (or 5 days supply if &lt;18 years old) per prescription?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>0013</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>5</td>
<td>0013</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Does the patient meet one of the following exemptions?</p>
<p>1) Diagnosis of active cancer treatment, palliative care, end-of-life/hospice care, sickle cell, severe burn, traumatic crushing of tissue, amputation, major orthopedic surgery </p>
<p>2) Prescriber attestation that patient is not opioid naïve (i.e., new to Medicaid or was on higher dose in hospital)</p>
<p>If yes, please submit documentation.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>0014</td>
</tr>
<tr class="odd">
<td>6</td>
<td>0014</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>1) Diagnosis code which must be for somatic type pain</p>
<p>2) Prescriber attestation that the benefits and risks of opioid therapy has been discussed with patient</p></td>
<td>Y</td>
<td>0015</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>7</td>
<td>0015</td>
<td></td>
<td>Select</td>
<td>Does the provider attest that OARRS has been reviewed before initially prescribing or personally furnishing any controlled substance?</td>
<td>Y </td>
<td>0016</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>8</td>
<td>0016</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of the patient’s indication, previous utilization, and requested length of therapy?</td>
<td>Y</td>
<td>0017</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>9</td>
<td>0017</td>
<td></td>
<td>Select</td>
<td>Initial short-acting requests can be authorized up to 90 days. Does this request meet this requirement?</td>
<td>Y</td>
<td>END (Pending Manual Review) </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>10</td>
<td>1001</td>
<td></td>
<td>Select</td>
<td>Is the request for a dose escalation?</td>
<td>Y </td>
<td>1002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1005</td>
</tr>
<tr class="odd">
<td>11</td>
<td>1002</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>Prescriber attestation that dose escalation is likely to result in improved function or pain control.</p></td>
<td>Y </td>
<td>1003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>12</td>
<td>1003</td>
<td></td>
<td>Select</td>
<td>Is the request for a cumulative daily dose greater than 80 MED?</td>
<td>Y </td>
<td>1004</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1005</td>
</tr>
<tr class="odd">
<td>13</td>
<td>1004</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Is the medication being prescribed by or in consultation with a pain specialist, specialist in the area of the body affected by pain, or anesthesiologist?</p>
<p>If yes, please submit documentation.</p></td>
<td>Y </td>
<td>1005</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>14</td>
<td>1005</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of the following?</p>
<p>1) Current treatment plan</p>
<p>2) Demonstrated adherence to treatment plan through progress notes, including pain and function scores, random urine screenings results reviewed, concerns addressed, and no serious adverse outcomes observed</p></td>
<td>Y</td>
<td>1006</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>15</td>
<td>1006</td>
<td></td>
<td>Select</td>
<td>Subsequent short-acting and dose escalation requests can be authorized up to 180 days. Does this request meet this requirement?</td>
<td>Y</td>
<td>END (Pending Manual Review) </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>16</td>
<td>1235 </td>
<td> </td>
<td>Free Text </td>
<td>Please provide the rationale for the medication, dose, and duration being requested.  </td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
<tr class="even">
<td>17</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
<tr class="odd">
<td>18</td>
<td>1237</td>
<td></td>
<td>Free Text</td>
<td>Prior Authorization for a preferred short-acting opioid is only required if the initial request (defined as no opioids in the previous 90 days) exceeds 30 MED AND/OR exceeds a 7 days supply (or 5 days supply if &lt;18 years old).</td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
</tbody>
</table>

<p>LENGTH OF AUTHORIZATIONS: For the course of therapy, up to 180 days.
Initial short-acting and long-acting requests may only be authorized for
up to 90 days.</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>**Last Approved **</td>
<td>9/21/2023</td>
</tr>
<tr>
<td><strong>Other</strong></td>
<td></td>
</tr>
</tbody>
</table>







  
  






                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "../../..", "features": ["navigation.instant", "navigation.tabs", "navigation.prune", "search.highlight", "content.action.edit"], "search": "../../../assets/javascripts/workers/search.6ce7567c.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    
      <script src="../../../assets/javascripts/bundle.56dfad97.min.js"></script>
      
    
  </body>
</html>